Redge, Inc. aims to provide sustainable and safe medical care to all over the world with clinical engineer technology. Medical devices are essential equipment for treating the patient in a hospital. However, the medical device failures are frequently happened in developing countries, resulting medical accidents and threatened patient’s lives. It is cause of lack of maintenance and education of medical devices in local area. In Japan, clinical engineer, national license is dealing with medical device to maintain high quality medicine. Therefore, Redge, Inc. provides “CeTrax”, packaging system including medical device management and education based on Japanese clinical engineer knowledge and experience. For management part, we provide a simple system that combines cloud database computing and AI image recognition. It leads to forecast medical device failure and balance supply & demand consumable parts based on prediction the working rate of medical device. For education part, combination of hands-on training and video contents will expand local medical provider resources. CeTrax will improve the quality and safety of medical devices in developing countries.

RealBone® Technology Co. Ltd. has developed a new surface modification technology for calcium phosphate powder which obtained a Taiwan invention patent (Cert. No.: I427050) and Japan patent (JPN: 5280403).
The technology improves the physicochemical properties of the derived biomedical ceramics by increasing the linkages between the particles to allow crystal growth. Accordingly, we have developed an excellent product “REALBONE” resorbable calcium phosphate bone graft substitute (injectable).

Compared with other products, it not only has better operability, but also has good injectability and disintegration resistance. The initial setting time is 9 minutes, and compressive strength is 18-24MPa. It can be applied to various surgical operations that require strength, even under load-bearing conditions. This product has obtained the Class II medical device license from Food and Drug Administration of Taiwan in 2021. It has passed the trial procedure and has won the tender from Taipei Veterans General Hospital, and is waiting for tender at National Taiwan University Hospital. As a result, the product has flourished due to its wide range of applications to accelerate healing and thus improve the quality of life. Just like RealBone® Tech. slogans “REALBONE, Reborn all your bone & are those who make others’ Real Bone healthy”.

Red Arrow Therapeutics’ chemists shape the behavior of proteins by carefully designing polymer-protein conjugates with controlled architecture, composition, size and stimuli responsive chemistry. Our unique approach can then generate prodrug-like proteins with optimal pharmacokinetics, biodistribution and targeted activation at disease sites without compromising the biological action of the proteins. With our novel platform, a broad range of valuable functional attributes will become accessible for therapeutic innovation. As a 1st pipeline, we focused on immunotherapy, where only 20% patients respond to standard immunoncological options, such as immune checkpoint inhibitors (ICIs). Because the immunosuppressive environment of cold tumors is the major reason for immunotherapy failure, Red Arrow Therapeutics has developed protein prodrugs that safely boost antitumor immunity. To this end, we have identified the hit formulation capable of tumor eradication, even in malignancies that are resistant to ICIs, and we will optimize this formulation before large-scale manufacturing, pre-clinical trials and clinical trials. We are convinced that our proprietary platform will attract Japanese investors and pharmaceuticals to jointly develop products, and we aim to achieve IPO with our pipelines toward blockbuster drugs and alliances.

Globally, eight million people suffered from Parkinson disease (PD) symptom called freezing of gait, which cause walking difficulties, high risk of falling ,fear and depression. PD number is about 1/100 after age of 60 and is rising associated with aging society. Rehab Happy Walk was founded by Dr. Peeraya, an inventor specialized in rehabilitation, and teams who strive to improve quality of PD’s life by living independently, not the burden of society.
　Our solution has been developed and proved based on patients and caregivers’ feedback in clinical research. The product was patents pending and will be launched within 2019, while continuouslly improving second version by 2020. Our market plan will initiate and focus in Thailand with collaboration with two Mahidol University hospitals, six hospitals in same district, and Thai Medical society, while attempt to find alliances in Japan in order to expand internationally, given Thailand and Japan moving to full aging society.The potential PD people are 150,000 in 2020. Our revenue in 2020 is $ 1.4 million and increase to $10 million in 2023, while NPV is $540,000 at 40% discount rate and IRR is 80%.
　We are looking for investors and fit alliances to join our vision and move forward.

The pandemic has brought to the forefront a challenge that organizational leaders have dealt with for decades: how
do I keep my team productive and high performing while also ensuring that they’re mentally resilient and engaged
with their roles? For a long time, we thought that these were two different challenges, but the pandemic has led
many organizations to the realization that both challenges are the same problem: just two sides of the same coin.

“A Nudge: A prompt that changes behaviour”.

We are the first to exclusively use personalized Nudges powered by Behavioral Science + Machine Learning to
incentivize your talents to be more effective, motivated and engaged.

Our solution is tried and tested: we have successfully increased organizational sales in real estate by 600%, while
also increasing retention by 22%.

Roceso Technologies is a world pioneer in soft robotic exoskeleton technologies. Its soft robotic solutions provide functional assistance to patients with limb motor function impairments during rehabilitation and daily living. The company’s flagship product, the EsoGLOVE, is one of the world lightest hand rehabilitation and exoskeleton devices offering top functionality and comfort. Since 2020, Roceso Technologies have expanded to three business units: Rehabilitation and Assistive Technologies, Venous Care and Contracture Management, Compression and Support.

♦ 2011.9 Rayark Inc. founded
♦ 2012 Q1 Cytus, music rhythm game, released on iOS and Android, to great acclaim
♦ 2012 Q4 Mandora, character based casual game, released on iOS and Android, 4 million downloads in 3 months
♦ 2013 Q2 & Q3 Scheduled releases of 2 new music rhythm games on mobile platforms
♦ 2013 Q4 Scheduled release of next-gen 3D action game

Rayark is a team of passionate game developers who are dedicated to creating high-quality gaming experiences on various platforms.

As a content provider, Rayark also seeks for integration of online/offline applications, such as the following events;

♦ Cytus live concert 2012 @Taipei
♦ Cytus musical 2013@Seoul
♦ Mandora collectibles pre-order
♦ Rayark artist collaboration 2013

As global population increases, the volume of garbage also increase and while we have made great leaps and bounds in digital and mobile technology, this has not been the case for waste management.

The real challenge for waste management solutions is sustainability. Is the solution economically viable? Can we afford to build, operate or maintain this solution? With the heightening awareness for global warming, we also now need to ask ourselves, is this solution environmentally sound?

RAD Green Solutions is a cleantech company based in Davao City, Philippines and we are here to take this challenge. We have developed a technology that allows us to produce more heat with less fuel with the aid of water which we call HYDROBURN.

With lots of potential applications for this technology, we decided to initially focus on an application for bio-medical wastes and we hope to eventually develop the most economical waste to energy solution for municipal garbage currently rotting in dumpsites and landfills all over the world.